SEL1L3 as a link molecular between renal cell carcinoma and atherosclerosis based on bioinformatics analysis and experimental verification
Aging · 2023
DOI: 10.18632/aging.205227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Haoyuan Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.
- Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.
Zitieren
APA
Wang, H., Ma, X., Li, S., & Ni, X. (2023). SEL1L3 as a link molecular between renal cell carcinoma and atherosclerosis based on bioinformatics analysis and experimental verification. Aging. https://doi.org/10.18632/aging.205227
Vancouver
Wang H, Ma X, Li S, Ni X. SEL1L3 as a link molecular between renal cell carcinoma and atherosclerosis based on bioinformatics analysis and experimental verification. Aging. 2023. doi:10.18632/aging.205227
BibTeX
@article{Wang2023,
author = {Wang, Haoyuan and Ma, Xiaopeng and Li, Sijie and Ni, Xiaochen},
title = {SEL1L3 as a link molecular between renal cell carcinoma and atherosclerosis based on bioinformatics analysis and experimental verification},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205227}
}
EUVIMED